Patient-centred and professional-directed implementation strategies for diabetes guidelines: A cluster-randomized trial-based cost-effectiveness analysis

Diabetic Medicine

Volumn 23, Issue 2, 2006, Pages 164-170

  Dijkstra, R F ^a   Niessen, L W ^b   Braspenning, J C C ^a   Adang, E ^a   Grol, R T P M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Cost effectiveness analysis; Delivery of health care; Diabetes mellitus; Patient participation

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CLUSTER ANALYSIS; COMPARATIVE STUDY; COMPUTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DIABETES EDUCATION; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; EDUCATION PROGRAM; FEMALE; GENERAL HOSPITAL; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT CARE; PATIENT CARE; PATIENT EDUCATION; PATIENT PARTICIPATION; PRACTICE GUIDELINE; PREDICTION; PROBABILITY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; VALIDATION STUDY;

AGED; COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH CARE COSTS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; LIFE EXPECTANCY; LONG-TERM CARE; MALE; MIDDLE AGED; PATIENT-CENTERED CARE; PRACTICE GUIDELINES; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 33645080434     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2005.01751.x     Document Type: Article

References (38)

1. King H Aubert RE Herman WH Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections Diabetes Care 1998 21 1414 1431
2. Amos AF McCarty DJ Zimmet P The rising global burden of diabetes and its complications: estimates and projections to the year 2010 Diabet Med 1997 14 Suppl. 5 S1 85
3. Jonsson B Revealing the cost of Type II diabetes in Europe Diabetologia 2002 45 Suppl. 7 S5 12
4. Os van N Niessen LW Koopmanschap MA van der Lei J Gedetailleerde raming van de maatschappelijke kosten van diabetes mellitus. [Detailed analysis of the societal costs of diabetes mellitus] Ned Tijdschr Geneeskd 2000 144 842 846
5. Williams R van Gaal L Lucioni C Assessing the impact of complications on the costs of Type II diabetes Diabetologia 2002 45 Suppl. 7 S13 S17
6. Klonoff DC Schwartz DM An economic analysis of interventions for diabetes Diabetes Care 2000 23 390 404
7. Mason J Freemantle N Nazareth I Eccles M Haines A Drummond M When is it cost-effective to change the behavior of health professionals? JAMA 2001 286 2988 2992
8. Niessen LW Grijseels EW Rutten FF The evidence-based approach in health policy and health care delivery Soc Sci Med 2000 51 859 869
9. Standl E Stiegler H Microalbuminuria in a random cohort of recently diagnosed type 2 (non-insulin-dependent) diabetic patients living in the greater Munich area Diabetologia 1993 36 1017 1020
10. Ismail N Becker B Strzelczyk P Ritz E Renal disease and hypertension in non-insulin-dependent diabetes mellitus Kidney Int 1999 55 1 28
11. Bommer J Prevalence and socio-economic aspects of chronic kidney disease Nephrol Dial Transplant 2002 17 8 12
12. Ratner RE Type 2 diabetes mellitus: the grand overview Diabet Med 1998 15 S4 S7
13. Fong DS Aiello L Gardner TW King GL Blankenship G Cavallerano JD et al. Diabetic retinopathy Diabetes Care 2003 26S 99 102
14. Ortegon M, Redekop K and Niessen LW. Cost-Effectiveness Analysis of Prevention and Treatment of Diabetic Neuropathy: a Markov Simulation Model Diabetes Care 2004 27 901 907
15. Dijkstra RF Braspenning JCC Grol R Empowering patients: how to implement a diabetes passport in hospital care Patient Educ Couns 2002 47 173 177
16. Dijkstra RF Braspenning JCC Huijsmans Z Akkermans RP van Ballegooie E ten Have P et al. Introduction of diabetes passports involving both patients and professionals to improve hospital outpatient diabetes care. Diabetes Res Clin Pract 2005 68 126 134 doi:10.1016/j.diabres
17. Dijkstra RF Braspenning JCC Uiters E van Ballegooie E Grol R Perceived barriers to the implementation of diabetes guidelines in hospitals in The Netherlands Neth J Med 2000 56 80 85
18. Gray A Raikou M McGuire A Fenn P Stevens R Cull C et al. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group BMJ 2000 320 1373 1378
19. Niessen LW Roads to Health - Multi-State Modelling of Population Health and Resource Use Amsterdam: Dutch University Press 2002
20. Niessen LW Dijkstra RF Hutubessy RC Rutten GE Casparie AF Lifetime health effects and costs of diabetes treatment in the Netherlands Neth J Med 2003 61 355 364
21. Polak BC Crijns H Casparie AF Niessen LW Cost-effectiveness of glycemic control and ophthalmological care in diabetic retinopathy Health Policy 2003 64 89 97
22. Os van N Niessen LW Bilo HJ Casparie AF van Hout BA Diabetes nephropathy in the Netherlands: a cost effectiveness analysis of national clinical guidelines Health Policy 2000 51 135 147
23. Krumholz HM Amatruda J Smith GL Mattera JA Roumanis SA Radford MJ et al. Randomized trial of an education and support intervention to prevent readmission of patients with heart failure J Am Coll Cardiol 2002 39 83 89
24. Gallefoss F Bakket PS Cost-benefit and cost-effectiveness analysis of self-management in patients with COPD-a 1-year follow-up randomized, controlled trial Respir Med 2002 96 424 431
25. Eastman RC Javitt JC Herman WH Dasbach EJ Copley-Merriman C Maier W et al. Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia Diabetes Care 1997 20 735 744
26. Redekop WK Koopmanschap MA Stolk RP Rutten GE Wolffenbuttel BH Niessen LW Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes Diabetes Care 2002 25 458 463
27. Niessen LW Casparie AF eds [Effects and Costs of the Revised Guidelines for DiabetesDiabetic Retinopathy, Diabetic Nephropathy, Diabetic Foot and Diabetes Control] Alphen a/D Rijn CBO/NDS/Imta van Zuiden 2001
28. Dijkstra RF Braspenning JCC et al. Patients and nurses determine variation in adherence to guidelines at Dutch hospitals more than internists or settings Diabet Med 2004 21 586 591
29. Oostenbrink JB Koopmanschap MA Rutten FHH Standardisation of costs: the Dutch Manual for Costing in economic evaluations Pharmacoeconomics 2002 20 443 454
30. Hutubessy R Niessen LW Dijkstra R Casparie AF Rutten FFH Stochastic league tables for diabetes treatment in The Netherlands Health Econ 2005 14 445 455
31. Oers van JAM ed [Health on Course? the 2002 Dutch Public Health Status and Forecasts Report] [WWW document]. Houten Bohn Stafleu Van Loghum, 2002. URL [accessed on October 2004] (In Dutch, English summary)
32. Ballegooie van E Everdingen van JJ [CBO guidelines on diagnosis, treatment, and prevention of complication in diabetes mellitus: retinopathy, foot ulcers, nephropathy and cardiovascular diseases. Dutch Inst for Quality Assurance] Ned Tijdschr Geneeskd 2000 144 413 418 (in Dutch)
33. Dutch Diabetes Federation. [Guidelines on Diagnosis, Treatment and Prevention of Complications in Diabetes Mellitus. Retinopathy, Foot Ulcers, Nephropathy and Cardiovascular Diseases] Heerenveen Banda 1998 (in Dutch)
34. Rutten G Verhoeven S Heine R de Grauw W Cromme P Reenders K et al. Guideline on diabetes mellitus type 2. First revision Huisarts Wet 1999 42 67 84 (in Dutch)
35. Grimshaw JM Thomas RE MacLennan G Fraser C Ramsay CR Vale L et al. Effectiveness and efficiency of guideline dissemination and implementation strategies Health Technol Assess 2004 8 1 71
36. Dijkstra R Implementing Diabetes Guidelines at outpatient clinics; patient-centred and professional directed approaches. Wageningen: Ponsen & Looijen 2004
37. Glasgow RE Anderson RM In diabetes care, moving from compliance to adherence is not enough. Something entirely different is needed Diabetes Care 1999 22 2090 2092
38. Song SH Brown PM Coronary heart disease risk assessment in diabetes mellitus: comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications Diabet Med 2004 21 238 245